We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)

This study has been withdrawn prior to enrollment.
(Withdrawn due to lack of accrual per Center DSMP, with PI concurrence)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01011998
First Posted: November 11, 2009
Last Update Posted: September 27, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: July 2010
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)